Engage: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study To Investigate The Efficacy And Safety Of Eliglustat In Adults With Gaucher Disease Type 1: 9 Month Results
BLOOD（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要